Virulence factor profiles and antimicrobial susceptibilities of ocular Bacillus isolates

Current Eye Research

Volumn 31, Issue 9, 2006, Pages 693-702

  Callegan, Michelle C ^a,b,e   Cochran, Daniel C ^a,b   Kane, Scott T ^a,b   Ramadan, Raniyah T ^b,c   Chodosh, James ^a,b   McLean, Celeste ^d   Stroman, David W ^d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d ALCON RESEARCH LTD   (United States)

^e NONE   (United States)

Author keywords

Bacillus cereus; Bacillus thuringiensis; Endophthalmitis; Eye; Keratitis; Toxins

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; QUINOLONE DERIVATIVE; VANCOMYCIN; VIRULENCE FACTOR;

AMPLIFIED RIBOSOMAL DNA RESTRICTION ANALYSIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTERIAL EYE INFECTION; BACTERIUM ISOLATE; CELL KILLING; CONTROLLED STUDY; CORNEA CELL; EYE TOXICITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA CELL;

ANTI-BACTERIAL AGENTS; BACILLUS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CELLS, CULTURED; CONNECTIVE TISSUE CELLS; CORNEA; DNA, BACTERIAL; EYE INFECTIONS, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RETINA; VIRULENCE; VIRULENCE FACTORS;

EID: 33748569098     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680600850963     Document Type: Article

References (54)

1. Carretto E, Barbarini D, Poletti F, et al. Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit. Scand J Infect Dis. 2000;32:98-100.
2. Centers for Disease Control and Prevention (CDC). Outbreak of cutaneous Bacillus cereus infections among cadets in a university military program-Georgia, August 2004. MMWR Morb Mortal Wkly Rep. 2005;54:1233-1235.
3. Gaur AH, Patrick CC, McCullers JA, et al. Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin Infect Dis. 2001;32:1456-1462.
4. Hernaiz C, Picardo A, Alos JI, Gomez-Garces JL. Nosocomial bacteremia and catheter infection by Bacillus cereus in an immunocompetent patient. Clin Microbiol Infect. 2003;9:973-975.
5. Helgason E, Caugant DA, Olsen I, Kolsto AB. Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J Clin Microbiol. 2000;38:1615-1622.
6. Mori T, Tokuhira M, Takae Y, et al. Successful non-surgical treatment of brain abscess and necrotizing fasciitis caused by Bacillus cereus. Intern Med. 2002;41:671-673.
7. Darbar A, Harris IA, Gosbell IB. Necrotizing infection due to Bacillus cereus mimicking gas gangrene following penetrating trauma. J Orthop Trauma. 2005;19:353-355.
8. Strauss R, Mueller A, Wehler M, et al. Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin Infect Dis. 2001;33:E39-41.
9. Callegan MC, Engelbert M, Parke DW, et al. Bacterial endophthalmitis: Epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
10. Cowan CL, Madden WM, Hatem GF, Merritt JC. Endogenous Bacillus cereus panophthalmitis. Ann Ophthalmol. 1987;19:65-68.
11. Davey RT, Tauber WB. Posttraumatic endophthalmitis: The emerging role of Bacillus cereus infection. Rev Infect Dis. 1987;9:110-123.
12. David DB, Kirkby GR, Noble BA. Bacillus cereus endophthalmitis. Br J Ophthalmol. 1994;78:577-580.
13. Shamsuddin D, Tuazon CU, Levy C, Curtin J. Bacillus cereus panophthalmitis: Source of the organism. Rev Infect Dis. 1982;4:97-103.
14. Callegan MC, Kane ST, Cochran DC, et al. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun. 2003;71:3116-3124.
15. Callegan MC, Kane ST, Cochran DC, et al. Bacillus endophthalmitis: Roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci. 2005;46:3233-3238.
16. Das T, Choudhury K, Sharma S, et al., and Endophthalmitis Research Group. Clinical profile and outcome in Bacillus endophthalmitis. Ophthalmology. 2001;108:1819-1825.
17. Damgaard PH, Granum PE, Bresciani J, et al. Characterization of Bacillus thuringiensis isolated from infections in burn wounds. FEMS Immunol Med Microbiol. 1997;18:47-53.
18. Gaviria Rivera AM, Granum PE, Priest FG. Common occurrence of enterotoxin genes and enterotoxicity in Bacillus thuringiensis. FEMS Microbiol Lett. 2000;190:151-155.
19. Hansen BM, Hendriksen NB. Detection of enterotoxic Bacillus cereus and Bacillus thuringiensis strains by PCR analysis. Appl Environ Microbiol. 2001;67:185-189.
20. Hernandez E, Ramisse F, Ducoureau JP, et al. Bacillus thuringiensis subsp. konkukian (serotype H34) superinfection: Case report and experimental evidence of pathogenicity in immunosuppressed mice. J Clin Microbiol. 1998;36:2138-2139.
21. Hsieh YM, Sheu SJ, Chen YL, Tsen HY. Enterotoxigenic profiles and polymerase chain reaction detection of Bacillus cereus group cells and B. cereus strains from foods and food-borne outbreaks. J Appl Microbiol. 1999;87:481-490.
22. Samples JR, Buettner H. Corneal ulcer caused by a biologic insecticide (Bacillus thuringiensis). Am J Ophthalmol. 1983;95:258-260.
23. Samples JR, Buettner H. Ocular infection caused by a biological insecticide. J Infect Dis. 1983;148:614.
24. Guttmann DM, Ellar DJ. Phenotypic and genotypic comparisons of 23 strains from the Bacillus cereus complex for a selection of known and putative B. thuringiensis virulence factors. FEMS Microbiol Lett. 2000;188:7-13.
25. Tayabali AF, Seligy VL. Human cell exposure assays of Bacillus thuringiensis commercial insecticides: Production of Bacillus cereus-like cytolytic effects from outgrowth of spores. Environ Health Perspect. 2000;108:919-930.
26. Yang CY, Pang JC, Kao SS, Tsen HY. Enterotoxigenicity and cytotoxicity of Bacillus thuringiensis strains and development of a process for Cry1Ac production. J Agric Food Chem. 2003;51:100-105.
27. Rasko DA, Altherr MR, Han CS, Ravel J. Genomics of the Bacillus cereus group of organisms. FEMS Microbiol Rev. 2005;29:303-329.
28. Cherif A, Brusetti L, Borin S, et al. Genetic relationship in the 'Bacillus cereus group' by rep-PCR fingerprinting and sequencing of a Bacillus anthracis-specific rep-PCR fragment. J Appl Microbiol. 2003;94:1108-1119.
29. Ivanova N, Sorokin A, Anderson I, et al. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature. 2003;423:87-91.
30. Read TD, Peterson SN, Tourasse N, et al. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature. 2003;423:81-86.
31. Chang YH, Shangkuan YH, Lin HC, Liu HW. PCR assay of the groEL gene for detection and differentiation of Bacillus cereus group cells. Appl Environ Microbiol. 2003;69:4502-4510.
32. Manzano M, Cocolin L, Cantoni C, Comi G. Bacillus cereus, Bacillus thuringiensis and Bacillus mycoides differentiation using a PCR-RE technique. Int J Food Microbiol. 2003;81:249-254.
33. Daffonchio D, Raddadi N, Merabishvili M, et al. Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis. Appl Environ Microbiol. 2006;72:1295-1301.
34. Valjevac S, Hilaire V, Lisanti O, et al. Comparison of minisatellite polymorphisms in the Bacillus cereus complex: A simple assay for large-scale screening and identification of strains most closely related to Bacillus anthracis. Appl Environ Microbiol. 2005;71:6613-6623.
35. Hoffmaster AR, Ravel J, Rasko DA, et al. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci USA. 2004;101:8449-8454.
36. Cone LA, Dreisbach L, Potts BE, et al. Fatal Bacillus cereus endocarditis masquerading as an anthrax-like infection in a patient with acute lymphoblastic leukemia: Case report. J Heart Valve Dis. 2005;14:37-39.
37. Hill KK, Ticknor LO, Okinaka RT, et al. Fluorescent amplified fragment length polymorphism analysis of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis isolates. Appl Environ Microbiol. 2004;70:1068-1080.
38. Ko KS, Kim JM, Kim JW, et al. Identification of Bacillus anthracis by rpoB sequence analysis and multiplex PCR. J Clin Microbiol. 2003;4:2908-2914.
39. Helgason E, Caugant DA, Lecadet MM, et al. Genetic diversity of Bacillus cereus/B. thuringiensis isolates from natural sources. Curr Microbiol. 1998;37:80-87.
40. Schaeffer P, Millet J, Aubert JP. Catabolic repression of bacterial sporulation. Proc Natl Acad Sci USA. 1965;54:704-711.
41. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun. 1999;67:3357-3366.
42. Callegan MC, Cochran DC, Kane ST, et al. Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect Immun. 2002;70:5381-5389.
43. Limb GA, Salt TE, Munro PM, et al. In vitro characterization of a spontaneously immortalized human Muller cell line (M10-M1). Invest Ophthalmol Vis Sci. 2002;43:864-869.
44. Jett BD, Hatter KL, Huycke MM, Gilmore MS. Simplified agar plate method for quantifying viable bacteria. Biotechniques. 1997;23:648-650.
45. Callegan MC, Ramirez R, Kane ST, et al. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003;20:246-252.
46. Rowan NJ, Caldow G, Gemmell CG, Hunter IS. Production of diarrheal enterotoxins and other potential virulence factors by veterinary isolates of bacillus species associated with nongastrointestinal infections. Appl Environ Microbiol. 2003;69:2372-2376.
47. Rowan NJ, Deans K, Anderson JG, et al. Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol. 2001;67:3873-3881.
48. Callegan MC, Kane ST, Cochran DC, Gilmore MS. Molecular mechanisms of Bacillus endophthalmitis pathogenesis. DNA Cell Biol. 2002;21:367-373.
49. Callegan MC, Kane ST, Cochran DC, et al. Bacillus endophthalmitis: Roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci. 2005;46:3233-3238.
50. Kuppe A, Evans LM, McMillan DA, Griffith OH. Phosphatidylinositol- specific phospholipase C of Bacillus cereus: Cloning, sequencing, and relationship to other phospholipases. J Bacteriol. 1989;171:6077-6083.
51. Johansen T, Holm T, Guddal PH, et al. Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene. 1988;65:293-304.
52. Henirichs JH, Beecher DJ, Macmillan JD, Zilinskas BA. Molecular cloning and characterization of the hblA gene encoding the B component of hemolysin BL from Bacillus cereus. J Bacteriol. 1993;175:6760-6766.
53. Ryan PA, Macmillan JD, Zilinskas BA. Molecular cloning and characterization of the genes encoding the L1 and L2 components of hemolysin BL from Bacillus cereus. J Bacteriol. 1997;179:2551-2556.
54. Gilmore MS, Cruz-Rodz AM, Leimeister-Wächter M, et al. A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: Nucleotide sequence and genetic linkage. J Bacteriol. 1989;171:744-753.